Toward Early Detection and Intervention in Schizophrenia
Friday, October 12, 2007 • Speakers, Titles and Outlines
Click on the request buttons below to obtain powerpoint presentations for each speaker
Deborah Levy, Ph.D.
The Diversity of Gene Expression in Schizophrenia
• Why it has been so difficult to find schizophrenia susceptibility genes.
• Certain traits that are over-represented in well relatives of schizophrenics can increase power to detect genes for schizophrenia.
• The most promising endophenotypes for finding schizophrenia genes.
Stephen R. Marder, M.D.
New Therapeutic Targets in Schizophrenia: Focus on Cognition and Negative Symptoms
• Factors that are associated with functional outcomes in schizophrenia.
• Recent pharmacological approaches to improving cognition in schizophrenia.
• Recent evidence of the effectiveness of psychosocial approaches to improving cognition and negative symptoms.
Paul Root Wolpe, Ph.D.
The Ethical Dilemma of Presymptomatic Treatment
in Serious Mental Illness
• The ethical conundrums of pre-symptomatic treatment of mental illness.
• Recognizing new technologies that may make this an emerging clinical issue.
• Some ethical principles and tools to analyze and consider.
Jean Addington, Ph.D.
Treatment for the Prodrome: Are We Ready for Clinical Practice
• The concept of clinical high-risk for psychosis.
• Current treatment options for clinical high-risk individuals, with an emphasis on cognitive behavioral therapy approaches.
• The advantages and disadvantages of treatment in the pre-psychotic stage.
Scott Woods, M.D.
Treatment Research Findings for the Psychosis Prodrome.
• Focus for treatment in individuals with prodromal symptoms of schizophrenia.
• Reasons why treatment noncompliance is a significant obstacle.
• The advantages and disadvantages of psychopharmalogical interventions in this population.
Elaine Walker, Ph.D.
The Manifestation and Progression of the Prodrome in Adolescents.
• Key issues regarding normal adolescent neuromaturation.
• Recent theories concerning post-pubertal maturational processes that may have implications for psychopathology.
• Recent findings on the factors that predict the progression of prodomal symptoms in adolescents at risk for psychosis.
